Malaysian Genomics Resource Centre Berhad (KLSE:MGRC)

KLSE:MGRC Balance Sheet

Financials in millions MYR. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	4.31	1.02	0.27	1.42	1.69	20.52
Short-Term Investments	-	2.47	2.82	5.94	-	0.13
Cash & Short-Term Investments	4.31	3.49	3.09	7.36	1.69	20.65
Cash Growth	2933.10%	12.86%	-58.04%	334.71%	-91.80%	82.56%
Accounts Receivable	7.81	2.6	4.33	4.21	3.64	8.5
Other Receivables	0.25	0.14	0.23	0.15	15.52	0.06
Receivables	8.07	2.73	4.56	4.37	19.16	8.57
Inventory	0.77	0.39	0.94	0.62	0.44	0.38
Prepaid Expenses	-	0.19	0.25	0.54	-	0.47
Other Current Assets	0.24	2.75	2.75	3.19	0.14	-
Total Current Assets	13.38	9.55	11.59	16.07	21.43	30.06
Property, Plant & Equipment	2.85	3.2	4.39	5.34	4.94	5.8
Long-Term Investments	2.5	2.5	2.5	-	-	-
Other Intangible Assets	3.25	3.46	3.88	4.29	4.51	4.95
Long-Term Deferred Tax Assets	-	-	-	-	-	1.08
Total Assets	21.97	18.71	22.36	25.7	30.87	41.89

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jun 30, 2023	Jun 30, 2022
Accounts Payable	1.98	0.01	0.29	0.01	1.33	0.07
Accrued Expenses	-	1.66	1.77	1.16	-	0.67
Current Portion of Leases	0.32	0.31	0.38	0.36	0.39	0.37
Current Income Taxes Payable	-	-	-	-	-	0.05
Current Unearned Revenue	0.03	0.03	0.04	0.29	0.08	0.01
Other Current Liabilities	-	1	1.08	0.19	-	0.49
Total Current Liabilities	2.33	3	3.56	2.01	1.79	1.66
Long-Term Leases	0.76	0.92	1.23	1.61	0.87	1.26
Total Liabilities	3.09	3.92	4.78	3.62	2.66	2.92

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jun 30, 2023	Jun 30, 2022
Common Stock	19.85	17.44	59.44	59.44	56.61	52.62
Retained Earnings	0.14	-1.66	-41.28	-37.09	-29.82	-15.57
Total Common Equity	19.99	15.77	18.16	22.35	26.79	37.05
Minority Interest	-1.11	-0.99	-0.58	-0.26	1.43	1.92
Shareholders' Equity	18.88	14.78	17.57	22.09	28.21	38.97
Total Liabilities & Equity	21.97	18.71	22.36	25.7	30.87	41.89

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jun 30, 2023	Jun 30, 2022
Total Debt	1.08	1.23	1.61	1.97	1.26	1.62
Net Cash (Debt)	3.23	2.26	1.48	5.39	0.43	19.02
Net Cash Growth	-	52.82%	-72.57%	1141.87%	-97.72%	96.91%
Net Cash Per Share	0.02	0.02	0.01	0.03	0.00	0.15
Filing Date Shares Outstanding	150	150.93	137.21	137.21	130.21	124.21
Total Common Shares Outstanding	150	137.21	137.21	137.21	130.21	124.21
Working Capital	11.05	6.54	8.03	14.06	19.64	28.4
Book Value Per Share	0.13	0.11	0.13	0.16	0.21	0.30
Tangible Book Value	16.74	12.32	14.28	18.05	22.28	32.1
Tangible Book Value Per Share	0.11	0.09	0.10	0.13	0.17	0.26
Machinery	-	7.17	7.32	7.31	-	7.72
Construction In Progress	-	0.21	0.21	0.21	-	-

Data Source: S&P Global Market Intelligence Last updated: Jun 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Sep 1, 2026

Data Sources Report a data error